Since cancer-specific gain-of-function mutations were reported in PIK3CA gene (Campbell et al., 2004; Samuels and Velculescu, 2004), which encodes the p110α PI3K, this isoform has been placed in the center of cancer research. This evidence concerns the gene PIK3CA and cancer.